Silo Pharma Inc (SILO) Financials

$2.50

$0.06 (2.46%)

As on 02-Sep-2026 16:00EDT

Market cap

$4 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.05	0.07	0.07	0.07	0.07	0.07
Cost of Revenue	0.31	0.89	0.01	0.01	0.01	0.01
Gross Profit	-0.26	-0.81	0.07	0.07	0.07	0.07
Operating Expenses	4.21	3.47	4.77	3.92	3.69	2.81
Operating Profit (EBIT)	-4.46	-4.28	-4.71	-3.86	-3.63	-2.74
Other Income	--	--	--	--	--	--
Profit before Tax	-4.47	-4.23	-4.39	-3.63	-3.91	4.18
Provision for Tax	--	--	--	0.07	0.00	0.02
Profit after Tax (Net Income)	-4.47	-4.23	-4.39	-3.70	-3.91	3.90
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	2.50

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	4.89	6.31	5.03	6.18	10.34	9.06
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.65	0.72	0.79	0.87	0.94
Current Liabilities	1.07	0.65	1.66	0.78	0.44	0.49
Total Liabilities	7.02	7.61	7.41	7.75	11.64	10.49

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.24	0.22	0.30	0.06	0.07	0.09
Current Assets	5.71	7.39	7.11	7.68	11.57	10.40
Total Assets	11.67	7.61	7.41	7.75	11.64	10.49
Total Debt*	--	--	--	--	--	--
Net Current Assets	--	6.74	5.46	6.91	11.14	9.91

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-4.66	-3.83	-3.22	-3.50	-2.28
Cash Flow from Investing Activities	--	0.64	0.97	-4.15	0.09	7.19
Cash from Financing Activities	--	4.86	3.24	-0.47	4.94	3.79
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-5.34	-4.76	-14.69	-19.11	-27.37	30.52
Cash EPS ($)	--	-4.75	-14.67	-19.11	-27.37	30.52
Adjusted Book Value ($)	--	7.10	16.84	31.89	72.41	70.85
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-5.25	-12.82	-16.65	-24.49	-17.81
Free Cash Flow per Share ($)	--	-5.25	-12.82	-16.65	-24.49	-17.81

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-74.56	-78.37	-44.81	-40.29	75.35
ROE (%)	-79.91	-74.56	-78.37	-44.81	-40.29	75.49
ROA (%)	-46.18	-56.31	-57.96	-38.17	-35.32	65.52
EBIT Margin (%)	-8,495.00	-5,811.76	-6,085.54	-5,347.42	-5,059.02	-3,850.95
Net Margin (%)	-8,269.53	-5,863.50	-6,092.59	-5,132.57	-5,420.86	5,477.86
Cash Profit Margin (%)	-0.94	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-25.00	--	--	--	0.01	0.74
EBIT Growth (%)	7.27	4.50	-13.80	-5.70	-32.92	-6.66
Net Profit Growth (%)	8.65	3.76	-18.70	5.32	-200.12	228.52
EPS Growth (%)	65.23	0.68	0.23	0.30	-1.90	1.88
Book Value Growth (%)	-62.13	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	--	--	-0.08	-0.12	0.00
Price / Book Value	0.91	--	--	0.05	0.05	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.56	--	--	2.04	2.79	-2.45
Close Price ($)	6.21	--	--	21.60	50.40	2.14
High Price ($)	6.78	--	--	98.40	148.80	7.59
Low Price ($)	4.88	--	--	18.24	1.34	1.80
Market Cap ($ Cr)	4.45	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	0.11	0.04	0.05
Current Ratio	5.36	11.36	4.29	9.90	26.52	21.23
Quick Ratio	5.36	--	--	--	--	21.35
Interest Coverage	-111.29	-112.34	-863.06	-791.87	-1,658.78	-903.93

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	91.55	85.89
Asset Turnover	0.01	0.01	0.01	0.01	0.01	0.01
Receivable days	--	--	--	334.39	322.23	217.08
Inventory Days	--	--	--	--	-3,829.56	-1,011.88
Payable days	--	445.60	71,554.18	33,400.04	24,467.40	19,890.43
Cash Conversion Cycle	--	--	--	--	-27,974.73	-20,685.23

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.